Caribou Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $175.4M
Liabilities Breakdown FY2025
Total Liabilities: $53.2M
Asset Breakdown
Total Assets: $175.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $12.4M | 7.0% |
| Accounts Receivable | $69.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.8M | 3.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $156.2M | 89.1% |
Liabilities Breakdown
Total Liabilities: $53.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.8M | 10.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $47.4M | 89.1% |